COVID-19 Vaccine and Long COVID: A Scoping Review.
COVID-19 Vaccine and Long COVID: A Scoping Review.
复制标题
DOI：
10.3390/life12071066
复制
发表时间：
2022-07-16
期刊：
影响因子：
3.2
通讯作者：
Sheikh, Abu Baker
中科院分区：
文献类型：
--
作者：
Mumtaz, Aqsa;Sheikh, Abdul Ahad Ehsan;Khan, Amin Moazzam;Khalid, Subaina Naeem;Khan, Jehanzaeb;Nasrullah, Adeel;Sagheer, Shazib;Sheikh, Abu Baker
随着 COVID-19 大流行的进展，有关 COVID-19 急性后遗症（特别是长期 COVID）的定义和治疗方法的变化已成为人们极大兴趣和研究的主题。该研究旨在描述病理生理学并讨论目前可用于长期新冠肺炎的不同治疗药物。另一个目标是评估不同类型疫苗对长期新冠肺炎症状的比较功效。使用 Ovid Medline、Embase、medRxiv 和 NIH COVID-19 产品组合进行了初步搜索。我们的综述中总共纳入了 16 项研究。尽管一些数据显示结果存在差异，但大多数接种疫苗的患者报告长期新冠症状有所改善，且各类疫苗之间没有显着差异。需要进一步的试验来更好地确定疫苗对长期新冠病毒的比较疗效并确定其他治疗方式。
As the COVID-19 pandemic progresses, changing definitions and therapeutics regarding the post-acute sequela of COVID-19, particularly long COVID, have become a subject of great interest and study. The study aims to describe the pathophysiology and discuss different therapeutic agents currently available for long COVID. Another objective is to assess comparative efficacy between different types of vaccines on symptoms of long COVID. A preliminary search was conducted using Ovid Medline, Embase, medRxiv, and NIH COVID-19 portfolios. A total of 16 studies were included in our review. Despite some of the data showing variable results, most of the vaccinated patients reported improvement in long COVID symptoms with no significant difference between various types of vaccines. Further trials are needed to better identify the comparative efficacy of vaccines for long COVID and ascertain other therapeutic modalities.
登录
查看更多内容
DOI：
10.1016/j.cmi.2022.03.016
发表时间：
2022-08
期刊：
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子：
--
作者：
Peghin M;De Martino M;Palese A;Gerussi V;Bontempo G;Graziano E;Visintini E;D'Elia D;Dellai F;Marrella F;Fabris M;Curcio F;Sartor A;Isola M;Tascini C
通讯作者：
Tascini C
影响因子：
17.3
作者：
Aiyegbusi OL;Hughes SE;Turner G;Rivera SC;McMullan C;Chandan JS;Haroon S;Price G;Davies EH;Nirantharakumar K;Sapey E;Calvert MJ;TLC Study Group
通讯作者：
TLC Study Group
DOI：
10.1016/s1473-3099(21)00460-6
发表时间：
2022-01
期刊：
The Lancet. Infectious diseases
影响因子：
--
作者：
Antonelli M;Penfold RS;Merino J;Sudre CH;Molteni E;Berry S;Canas LS;Graham MS;Klaser K;Modat M;Murray B;Kerfoot E;Chen L;Deng J;Österdahl MF;Cheetham NJ;Drew DA;Nguyen LH;Pujol JC;Hu C;Selvachandran S;Polidori L;May A;Wolf J;Chan AT;Hammers A;Duncan EL;Spector TD;Ourselin S;Steves CJ
通讯作者：
Steves CJ
DOI：
10.1056/nejmoa2116846
发表时间：
2022-01-27
期刊：
The New England journal of medicine
影响因子：
--
作者：
Gottlieb RL;Vaca CE;Paredes R;Mera J;Webb BJ;Perez G;Oguchi G;Ryan P;Nielsen BU;Brown M;Hidalgo A;Sachdeva Y;Mittal S;Osiyemi O;Skarbinski J;Juneja K;Hyland RH;Osinusi A;Chen S;Camus G;Abdelghany M;Davies S;Behenna-Renton N;Duff F;Marty FM;Katz MJ;Ginde AA;Brown SM;Schiffer JT;Hill JA;GS-US-540-9012 (PINETREE) Investigators
通讯作者：
GS-US-540-9012 (PINETREE) Investigators
影响因子：
64.8
作者：
Al-Aly, Ziyad;Xie, Yan;Bowe, Benjamin
通讯作者：
Bowe, Benjamin